Olmedo AAI, Cobo AC, Espinoza VBJ, Carrillo ER, Fabián SMGM

Language: Spanish
References: 9
Page: 621-623
PDF size: 181.47 Kb.

ABSTRACT

Rhabdomyolysis is a syndrome secondary to the destruction of cells of the skeletal muscle. The main complication of this clinical situation consists in the development of acute renal insufficiency. Drugs, mainly the statins can be considered as one of the main etiologies of this disease. We present the case of a patient who developed rhabdomyolysis secondary to the administration of statins.

REFERENCES

1. Harrison T, Fauci A, Braunwald E, Isselbacher K, et al. Harrison Principios de medicina interna. 17a ed. México: McGraw-Hill, 2009;1755,1758, 2006-2011.

2. Pierno S, Didonna MP, Cippone V, De Luca A, et al. Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study. Br J Pharmacol 2006;149:909-919.

3. Harriston S. A Review of Rhabdomyolysis. DCCN 2004;23:155-162.

4. Morrelli O, Estraviz O, Gutierrez L, Bridoux P, et al. Insuficiencia renal aguda por rabdomiólisis secundaria a hipolipemiantes. P Med Arg 2002;89(1):17-24.

5. Curiel E, Martín G, Rivera L. Rabdomiolisis causada por hipolipemiantes. Medicrit 2005;2(5):79-81.

6. Gangopadhyay K, Ryder R. Nontraumatic rhabdomyolysis: an unusual complication of diabetic hyperosmolar nonketotic (HONK) state. J R Soc Med 2006;99:200.

7. Marhuenda E. Estatinas en el tratamiento de dislipidemias. Ars Pharmaceutica 2002;43:83-85.

8. Chatzizisis YS. Revisión sobre la miopatía inducida por estatinas. SIICsalud 2010;1:1.

9. Abourjaily HM. Reacciones adversas asociadas con uso de atorvastatina y simvastatina. SIICsalud 2004;1:1.